175 related articles for article (PubMed ID: 22583043)
1. 7-Ethyl-10-hydroxycamptothecin proliposomes with a novel preparation method: optimized formulation, characterization and in-vivo evaluation.
Wang S; Ye T; Yang B; Yi X; Yao H
Drug Dev Ind Pharm; 2013 Feb; 39(2):393-401. PubMed ID: 22583043
[TBL] [Abstract][Full Text] [Related]
2. Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits.
Xu H; He L; Nie S; Guan J; Zhang X; Yang X; Pan W
J Control Release; 2009 Nov; 140(1):61-8. PubMed ID: 19651165
[TBL] [Abstract][Full Text] [Related]
3. Formulation, evaluation, and pharmacokinetics of isradipine proliposomes for oral delivery.
Bobbala SK; Veerareddy PR
J Liposome Res; 2012 Dec; 22(4):285-94. PubMed ID: 22762199
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of cyclosporin A-containing proliposomes: a comparison of the supercritical antisolvent process with the conventional film method.
Karn PR; Jin SE; Lee BJ; Sun BK; Kim MS; Sung JH; Hwang SJ
Int J Nanomedicine; 2014; 9():5079-91. PubMed ID: 25395846
[TBL] [Abstract][Full Text] [Related]
5. The preparation of Cistanche phenylethanoid glycosides liquid proliposomes: Optimized formulation, characterization and proliposome dripping pills in vitro and in vivo evaluation.
Li M; Li Y; Liu W; Li R; Qin C; Liu N; Han J
Eur J Pharm Sci; 2016 Oct; 93():224-32. PubMed ID: 27493021
[TBL] [Abstract][Full Text] [Related]
6. [Preparation of self-assemble nobiletin proliposomes and its pharmacokinetics in rats].
Lin W; Yao J; Zhou JP
Yao Xue Xue Bao; 2009 Feb; 44(2):192-6. PubMed ID: 19408692
[TBL] [Abstract][Full Text] [Related]
7. [Preparation of silymarin proliposomes and its pharmacokinetics in rats].
Xiao YY; Song YM; Chen ZP; Ping QN
Yao Xue Xue Bao; 2005 Aug; 40(8):758-63. PubMed ID: 16268514
[TBL] [Abstract][Full Text] [Related]
8. Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice.
Atyabi F; Farkhondehfai A; Esmaeili F; Dinarvand R
Acta Pharm; 2009 Jun; 59(2):133-44. PubMed ID: 19564139
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes.
Chen M; Li W; Zhang X; Dong Y; Hua Y; Zhang H; Gao J; Zhao L; Li Y; Zheng A
Int J Nanomedicine; 2017; 12():5487-5500. PubMed ID: 28814865
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization and in vivo studies of proliposomes containing Cyclosporine A.
Shah NM; Parikh J; Namdeo A; Subramanian N; Bhowmick S
J Nanosci Nanotechnol; 2006; 6(9-10):2967-73. PubMed ID: 17048505
[TBL] [Abstract][Full Text] [Related]
11. Proliposomes containing a bile salt for oral delivery of Ginkgo biloba extract: Formulation optimization, characterization, oral bioavailability and tissue distribution in rats.
Zheng B; Teng L; Xing G; Bi Y; Yang S; Hao F; Yan G; Wang X; Lee RJ; Teng L; Xie J
Eur J Pharm Sci; 2015 Sep; 77():254-64. PubMed ID: 26116277
[TBL] [Abstract][Full Text] [Related]
12. Development of a chemically stable 10-hydroxycamptothecin nanosuspensions.
Pu X; Sun J; Wang Y; Wang Y; Liu X; Zhang P; Tang X; Pan W; Han J; He Z
Int J Pharm; 2009 Sep; 379(1):167-73. PubMed ID: 19505545
[TBL] [Abstract][Full Text] [Related]
13. Preparation and evaluation of proliposomes containing propranolol hydrochloride.
Ahn BN; Kim SK; Shim CK
J Microencapsul; 1995; 12(4):363-75. PubMed ID: 8583311
[TBL] [Abstract][Full Text] [Related]
14. Daptomycin Proliposomes for Oral Delivery: Formulation, Characterization, and In Vivo Pharmacokinetics.
Arregui JR; Kovvasu SP; Betageri GV
AAPS PharmSciTech; 2018 May; 19(4):1802-1809. PubMed ID: 29616488
[TBL] [Abstract][Full Text] [Related]
15. Development of delayed-release proliposomes tablets for oral protein drug delivery.
Tantisripreecha C; Jaturanpinyo M; Panyarachun B; Sarisuta N
Drug Dev Ind Pharm; 2012 Jun; 38(6):718-27. PubMed ID: 21999514
[TBL] [Abstract][Full Text] [Related]
16. Preparation, Characterization, and in vivo Evaluation of NK4-Conjugated Hydroxycamptothecin-Loaded Liposomes.
Zhou T; Zhang W; Cheng D; Tang X; Feng J; Wu W
Int J Nanomedicine; 2020; 15():2277-2286. PubMed ID: 32280220
[TBL] [Abstract][Full Text] [Related]
17. Design, Characterization, and In Vivo Pharmacokinetics of Tacrolimus Proliposomes.
Nekkanti V; Rueda J; Wang Z; Betageri GV
AAPS PharmSciTech; 2016 Oct; 17(5):1019-29. PubMed ID: 26729532
[TBL] [Abstract][Full Text] [Related]
18. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.
Stano P; Bufali S; Pisano C; Bucci F; Barbarino M; Santaniello M; Carminati P; Luisi PL
J Liposome Res; 2004; 14(1-2):87-109. PubMed ID: 15461935
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of liposome-encapsulated codrug LMX.
Zhong Y; Wang J; Wang Y; Wu B
Int J Pharm; 2012 Nov; 438(1-2):240-8. PubMed ID: 22981689
[TBL] [Abstract][Full Text] [Related]
20. Modified hydrolysis kinetics of the active lactone moiety of 10-hydroxycamptothecin by liposomal encapsulation.
Shi K; Tian Y; Jiang Y; Wang L; Cui F
Pharm Dev Technol; 2010 Dec; 15(6):644-52. PubMed ID: 19943738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
